Wegovy : Up to 28 days at room temperature after first use
This is the number that got my attention: in the trial data, patients on oral semaglutide had dramatically higher discontinuation rates the "comparable" weight-loss results you see advertised only held for the small fraction who followed the strict protocol perfectly to the end
Complete an online consultation and our pharmacy team will assess whether treatment is clinically suitable for you
[1] [3] Current evidence suggests that dulaglutide and extended-release formulations generally demonstrate lower rates of nausea compared to twice-daily exenatide or higher doses of semaglutide and liraglutide used for weight management, though individual responses vary considerably
For weight management, it can be used by adults with a Body Mass Index (BMI) of 30 kg/m or more, or those with a BMI of 27-30 kg/m who have weight-related health conditions like prediabetes, high blood pressure, high cholesterol, or heart disease